Preirradiation evaluation and technical assessment of involved-field radiotherapy using computed tomographic (CT) simulation and neoadjuvant chemotherapy for intracranial germinoma
K. Kitamura et al., Preirradiation evaluation and technical assessment of involved-field radiotherapy using computed tomographic (CT) simulation and neoadjuvant chemotherapy for intracranial germinoma, INT J RAD O, 43(4), 1999, pp. 783-788
Citations number
45
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: To investigate the importance of preirradiation mental and endocri
nological evaluation, and the effectiveness of involved-field radiotherapy
following neoadjuvant chemotherapy,
Methods and Materials: Following etoposide and cisplatin with or without if
osfamide, 13 patients with nondisseminated disease received involved-field
irradiation of 24 Gy in 12 fractions within 3 weeks and 2 patients with dis
seminated germinoma received 24 Gy craniospinal irradiation (CSI), CT simul
ation was used to cover the tumor bed,
Results: Full-scale intelligence quotient (IQ) tests given at the time of t
he initial radiotherapy showed less than 90 in 7 of 11 patients who had tum
ors involving the neurohypophyseal region, but the 4 patients who had solit
ary pineal tumors showed higher scores. Panhypopituitarism was observed in
9 patients with tumors involving the neurohypophyseal region. All patients
are alive without disease, with a median follow-up period of 40 months. No
in-field relapse was noted after the involved-field radiotherapy. One patie
nt experienced a recurrence outside of the planning target volume.
Conclusion: Decline of neurocognitive and endocrine functions were often se
en in patients with tumors involving the hypophyseal region, but not in pat
ients with solitary pineal germinoma before radiotherapy. Involved-field ra
diotherapy using 24 Gy is effective with the help of CT simulation and neoa
djuvant chemotherapy. (C) 1999 Elsevier Science Inc.